Stay updated on Cabozantinib in Refractory Metastatic Colorectal Cancer Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib in Refractory Metastatic Colorectal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib in Refractory Metastatic Colorectal Cancer Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The footer’s site revision label changed from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T13:53:56.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    A site-wide banner announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to related updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T13:29:58.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The site footer revision label changes from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-18T14:43:07.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The footer revision marker changed from v3.7.0 to v3.7.1 while the study page remains inaccessible.
    Difference
    0.2%
    Check dated 2026-10-11T14:31:11.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden screen with site chrome, replacing the previous study details. This indicates the page is currently inaccessible due to permissions or server restrictions rather than a content update.
    Difference
    19%
    Check dated 2026-09-20T20:13:44.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    The page's revision tag changed from v3.6.5 to v3.6.6, indicating a new page revision. The visible study details appear unchanged by this metadata update.
    Difference
    0.1%
    Check dated 2026-08-30T21:39:36.000Z thumbnail image

Stay in the know with updates to Cabozantinib in Refractory Metastatic Colorectal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Refractory Metastatic Colorectal Cancer Clinical Trial page.